Sotera Health (SHC) Liabilities and Shareholders Equity (2020 - 2026)
Sotera Health (SHC) recorded quarterly Liabilities and Shareholders Equity of $3.2 billion in Q1 2026, down 0.84% quarter-over-quarter from $3.3 billion in Q4 2025, and up 4.47% on a YoY basis from $3.1 billion in Q1 2025.
Sotera Health (SHC) Liabilities and Shareholders Equity (2020 - 2026) Analysis & Trends
Sotera Health's Liabilities and Shareholders Equity history runs 7 years deep, the most recent figure standing at $3.2 billion for Q1 2026.
- In Q1 2026, Liabilities and Shareholders Equity rose 4.47% year-over-year to $3.2 billion; the TTM figure through Mar 2026 stood at $12.9 billion (up 4.25% YoY), while the FY2025 annual figure was $3.3 billion, up 6.24% from the prior year.
- Liabilities and Shareholders Equity was $3.2 billion for Q1 2026 at Sotera Health, down from $3.3 billion in the prior quarter.
- In the past five years, Liabilities and Shareholders Equity ranged from a high of $3.4 billion in Q1 2023 to a low of $2.8 billion in Q3 2022.
- Historically, Liabilities and Shareholders Equity has averaged $3.1 billion across 5 years, with a median of $3.1 billion in 2025.
- The sharpest annual moves came in 2023 and 2024: Liabilities and Shareholders Equity climbed 20.4% in 2023, then dropped 10.38% in 2024.
- A 5-year view of Liabilities and Shareholders Equity shows it stood at $3.1 billion in 2022, then advanced by 0.41% to $3.1 billion in 2023, then decreased by 1.88% to $3.1 billion in 2024, then advanced by 6.24% to $3.3 billion in 2025, then dropped by 0.84% to $3.2 billion in 2026.
- The last three Liabilities and Shareholders Equity figures came in at $3.2 billion (Q1 2026), $3.3 billion (Q4 2025), and $3.2 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | 24.53 Bn |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | 113.28 Bn |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | 83.54 Bn |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | 3.39 Bn |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | 13.07 Bn |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | 2.61 Bn |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | 29.68 Bn |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | 6.56 Bn |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | 3.67 Bn |
| 10 | Sotera Health | 4.72 Bn | 4.40 Bn | 147.07 Mn | 3.24 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.24 Bn |
| Dec 31, 2025 | 3.26 Bn |
| Sep 30, 2025 | 3.19 Bn |
| Jun 30, 2025 | 3.22 Bn |
| Mar 31, 2025 | 3.10 Bn |
| Dec 31, 2024 | 3.07 Bn |
| Sep 30, 2024 | 3.15 Bn |
| Jun 30, 2024 | 3.06 Bn |
| Mar 31, 2024 | 3.06 Bn |
| Dec 31, 2023 | 3.13 Bn |
| Sep 30, 2023 | 3.04 Bn |
| Jun 30, 2023 | 3.07 Bn |
| Mar 31, 2023 | 3.41 Bn |
| Dec 31, 2022 | 3.12 Bn |
| Sep 30, 2022 | 2.81 Bn |
| Jun 30, 2022 | 2.84 Bn |
| Mar 31, 2022 | 2.84 Bn |
| Dec 31, 2021 | 2.79 Bn |
| Sep 30, 2021 | 2.74 Bn |
| Jun 30, 2021 | 2.85 Bn |